L-Leucine is known to stimulate protein synthesis in L6 myotubes. In the present study, we examined the possible involvement of calcium signaling pathways in the stimulation of protein synthesis induced by L-leucine in L6 myotubes. After 16 h of treatment with L-leucinedepleted medium, the re-addition of L-leucine for 4 h augmented protein synthesis by about 50% as compared with an L-leucine-depleted control. Ryanodine receptor antagonists almost completely abolished the stimulatory effect of L-leucine, while IP 3 receptor antagonists showed partial inhibition when added simultaneously with L-leucine. These results suggest the possibility that calcium signaling pathways are involved in L-leucinestimulated protein synthesis.
Protein synthesis in mammalian cells is regulated by various factors, such as hormones, growth factors, amino acids, and carbohydrates. Among these regulatory factors, amino acids, in particular the branched-chain amino acids (BCAAs: leucine, isoleucine, and valine), are known to exert powerful regulatory influences on protein turnover. [1] [2] [3] We have reported that L-leucine stimulated protein synthesis in RLC-16 hepatocytes 4) and L6 myotubes cultured in L-leucine-deficient media. 5) Under L-leucine-deficient conditions, D-leucine did not exert such an effect. 4, 5) Likewise, L-histidine was found specifically to stimulate protein synthesis under basic amino acids (histidine, arginine, and lysine)-deficient conditions. 6) Although many studies have been performed to elucidate the modes of action of BCAA, the precise intracellular process regulated by BCAA remains unknown. For example, the mechanism of BCAA recognition by cells and the molecular events following amino acid recognition remain largely unknown. But, several signaling molecules have been reported to be involved in the BCAA signaling pathway. 7) Particularly, mTOR is believed to play the crucial role in amino acidinduced protein synthesis, while an mTOR-independent regulatory pathway (PKB/GSK-3/eIF2B axis) has also been reported. 8) Upon amino acid stimulation, the PI-3K/PKB axis is activated, leading to the activation of mTOR. Activated mTOR then phosphorylates 4E-BP1, which accelerates dissociation of 4E-BP1 from eIF-4E, or directly activates p70 S6 kinase and eEF2. We have reported the possible involvement of PKC in RLC-16 hepatocytes 4) and a rapid activation of PKC in plasma membrane and cytosol in L6 myotubes, 5) when L-leucine was added to either cell cultured in L-leucine-deficient media. PKC is known to be activated by diacylglycerol, which is produced by PLC-mediated cleavage of PIP 2 . IP 3 is simultaneously produced by cleavage of PIP 2 and is thought to induce calcium release from the endoplatimic reticulum (intracellular calcium store) by binding to its specific receptor, IP 3 receptors. We have observed that IP 3 receptor mRNA was induced in L6 myotubes cultured in L-leucine-depleted medium for 16 h (Nakazawa et al., unpublished observation). This result suggests an up-regulation of the IP 3 receptormediated signaling pathway under L-leucine deficiency. In fact, calcium signaling is known to play an important regulatory role in protein synthesis. 9, 10) Moreover, a calcium-dependent transcriptional pathway (calcium/ calcineurin/NF-AT pathway) has been reported to be involved in heart cardiac hypertrophy. 11) There are, however, few reports that imply the possible role of calcium signaling in BCAA-stimulated protein synthesis. These facts prompted us to examine the possible involvement of the calcium signaling pathway in Lleucine-induced protein synthesis in L6 myotubes.
L6 myoblasts, 12) kindly provided by Dr. T. Amano of the Mitsubishi-Kasei Institute of Life Sciences, Tokyo, were maintained in DMEM (Nissui Pharmaceutical, Tokyo) supplemented with 10% fetal bovine serum (FBS, JRH, Lenexa, KS), streptomycin (100 mg/ml, Wako Pure Chemicals, Osaka), and penicillin G (100 U/ y To whom correspondence should be addressed. Fax: +81-42-367-5713; E-mail: eiyouym@cc.tuat.ac.jp Abbreviations: 2-APB, 2-aminoethoxydiphenylborate; 4E-BP1, eIF4E-binding protein 1; DMEM, Dulbecco's Modified Eagle Medium; eEF2, eukaryotic elongation factor 2; eIF2B, eukaryotic intiation factor 2B; eIF4E, eukaryotic intiation factor 4E; GSK-3, glycogen synthase kinase-3; IP 3 , inositol triphosphate; mTOR, mammalian target of rapamycin; NF-AT, nuclear factor of activated T-cell; PI-3K, phosphoinositide-3-kinase; PIP 2 , phophatidylinositol bisphosphate; PKB, protein kinase B; PKC, protein kinase C; PLC, phospholipase C ml, Wako) (10% FBS/DMEM) under an atmosphere of 5% CO 2 /95% humidified air at 37 C, as described previously. 6, 13) L6 myoblasts were seeded at a density of 5 Â 10 4 cells/0.6 ml/well of 24-well culture plates (NUNC, Roskilde, Denmark) in 10% FBS/DMEM, and cultured for 9 d to form a confluent state. The medium was renewed every 3 d. After culturing for 9 d, cytosine -D-arabino-furanoside (Sigma-Aldrich Japan, Tokyo) was added at a concentration of 1 mM and cultured for another 3 d to form myotubes. Sufficient formation of myotubes was confirmed under phase contrast microscope in every experiment.
The protein synthesis activity of the L6 myotubes was determined as described previously. 6, 13) Briefly, the L6 myotubes were cultured for 16 h in 0.2% FBS/DMEM minus L-leucine (Kyokuto Seiyaku Kogyo, Tokyo), washed twice with Ca-Mg-free phosphate buffered saline (PBS (À)), and exposed to the experimental media for 3 h. Then 14.8 kBq of L-[ring-3, 5-
3 H] tyrosine (1850 GBq/mmol, Amersham Bioscience, Tokyo) was added to each well and cultured for another 1 h. After the cells were washed twice with PBS (À), ice-cold 10% trichloroacetic acid (TCA) was added and kept on ice for 30 min. The TCA-insoluble fraction was recovered, washed twice with ice-cold 10% TCA, dissolved in 0.1% SDS/0.2 N NaOH, and transferred to mini glass vials. Radioactivity was counted with a liquid scintillation spectrometer (LS5000 TD, Beckman-Coulter, Fullerton, CA). Portions of the lysate were taken, and protein concentration was assessed by Bradford protein assay (Bio-Rad Laboratories, Hercules, CA) using bovine serum albumin as a standard. The activity of protein synthesis was indicated by radioactivity/mg cellular protein (dpm/mg protein).
The re-addition of L-leucine to L-leucine-depleted media augmented protein synthesis by about 50% (Figs. 1 and 2) . To investigate the involvement of the calcium signaling pathway in L-leucine-induced protein synthesis, we examined the effects of antagonists for calcium release from intracellular calcium store on L-leucine-induced protein synthesis. Intracellular calcium is known to be released via two kinds of calcium releasing pathways in skeletal muscle cells, viz., IP 3 -induced calcium release (ICIR) and calcium-induced calcium release (CICR). 14) ICIR is mediated by the IP 3 receptor and CICR is mediated by the dihydorpyridine receptor (DHPR)-induced depolarization of cell membrane coupled with ryanodine receptors.
15) The effects of IP 3 receptor antagonists, 2-APB and heparin (sodium salt from bovine lung) (both obtained from Merck Japan, Tokyo) on L-leucine-induced protein synthesis were assessed. As shown in Fig. 1 Heparin was dissolved directly in DMEM. 2-APB was dissolved in ethanol and added to the medium at a final ethanol concentration of 0.1%. L6 myotubes precultured with L-leucine-depleted medium for 16 h were cultured in the presence or absence of L-leucine (0.8 mM, the concentration in the complete DMEM) and/or antagonists at the concentrations indicated in the figure for another 4 h. Protein synthesis was measured as described in the text. Data are expressed as means AE SEM for six wells. Statistical differences were compared by one-way analysis of variance followed by the Tukey-Kramer multiple comparisons test. Values not sharing a common letter are significantly different at P < 0:05.
did not affect protein synthesis when added alone, but L-leucine increased protein synthesis (Fig. 1A and B) . Forty mM of 2-APB partially cancelled L-leucine-induced protein synthesis (Fig. 1B) , while 25 mM of 2-APB showed no effect (Fig. 1A) . Heparin also partially inhibited L-leucine-induced protein synthesis in a dosedependent manner (Fig. 1C and D) . Although 2-APB and heparin showed partial cancellation of the L-leucine effect, these results suggest that intracellular calcium signaling might be involved in the L-leucine signaling pathway. Heparin reportedly inhibits IP 3 -induced calcium release, but weakly activates calcium release from ryanodine receptors. 16) As described above, calcium release in skeletal muscle cells is mediated via both IP 3 receptors and ryanodine receptors. The addition of heparin might inhibit IP 3 receptors, simultaneously activating ryanodine receptors, which leads to a partial decrease in the intracellular calcium concentration. Hence, we next examined the effects of ryanodine receptor antagonists, ryanodine (Merck Japan, Tokyo) and ruthenium red (Sigma-Aldrich Japan, Tokyo), on Lleucine-induced protein synthesis. Both ryanodine and ruthenium red completely cancelled L-leucine-induced protein synthesis, while they showed no effect on basal protein synthesis when added alone (Fig. 2) . These results clearly indicate that ryanodine receptor-mediated calcium release plays a crucial role in L-leucine-induced protein synthesis. After release from the calcium store, calcium activates calcium/calmodulin-dependent protein kinase (Ca/CaMK) and calcium-dependent protein phosphatase, calcineurin. Calcineurin is known to exert a transcriptional activation effect by dephophorylating NF-AT.
17) The involvement of other transcription factors (SRF, AP-1, CREB, etc.) in the calcium-dependent alteration of gene transcription is also known. 18) Although the possibility that an increase in intracellular calcium concentration induced by L-leucine stimulates protein synthesis by activating gene transcription via calcineurin/NF-AT or other calcium-dependent transcription factors cannot be excluded, the calciumdependent stimulatory effect of L-leucine on protein synthesis observed in this study appears to be mediated by activation and/or inactivation of translational factors, because stimulation of protein synthesis via activation of gene transcription generally is thought to take at least several days, 11, 18) but the stimulatory effects in this study were observed at only 4 h after the re-addition of Lleucine. Among eukaryotic translation factors, eEF-2 has been reported to be phophorylated by eEF-2 kinase, which is Ca/CaMK, thus inhibiting EF-2 activity. 19) That report appears to contradict the results obtained in this study. If the re-addition of L-leucine augmented the intracellular calcium concentration, the released calcium might per se inhibit eEF-2 activity by activating eEF-2 kinase, leading to inhibition of protein synthesis. At present, we have no data to explain this discrepancy, but in the translation process, the regulation at elongation steps is thought to be less important than that at initiation steps, and eEF-2 kinase is also known to be inactivated by phosphorylation at Ser 366 by p70 S6 kinase. 7) Calcium might activate mTOR or other unidentified Ca-related signaling molecules, thus activating p70 S6 kinase, which cancels the inhibitory effect of calcium on eEF-2. In fact, Conus et al. reported that calcium activated p70 S6 kinase via the PI-3K dependent pathway. 20) Rybkin et al. also reported that phosphorylation of eIF4E-BP1 was induced via the calciumdependent pathway. 21) In conclusion, we report that IP 3 receptor and ryanodine receptor antagonists partially or completely cancelled L-leucine-induced protein synthesis in L6 myotubes. As mentioned above, the molecular entity of BCAA recognition by cells is unclear at present. Thus the precise mechanism for the activation of calcium release by L-leucine is difficult to discuss. Although further analysis is required to clarify the precise Ruthenium red was dissolved directly in DMEM. Ryanodine was dissolved in ethanol and added to the medium at a final ethanol concentration of 0.1%. L6 myotubes precultured with L-leucine-depleted medium for 16 h were cultured in the presence or absence of L-leucine (0.8 mM, the concentration in the complete DMEM) and/or antagonists at the concentrations indicated in the figure for another 4 h. Protein synthesis was measured as described in the text. Data are expressed as means AE SEM for six wells. Statistical differences were compared by one-way analysis of variance followed by the Tukey-Kramer multiple comparisons test. Values not sharing a common letter are significantly different at P < 0:05.
physiological significance of the phenomenon observed in this study, this is the first report that describes the possible involvement of calcium signaling pathways in L-leucine-induced protein synthesis.
